Insulin action in the brain: cell types, circuits, and diseases

[1]  B. Lowell,et al.  Insulin signalling in tanycytes gates hypothalamic insulin uptake and regulation of AgRP neuron activity , 2021, Nature Metabolism.

[2]  W. Banks,et al.  The Blood–Brain Barrier, Oxidative Stress, and Insulin Resistance , 2021, Antioxidants.

[3]  C. Kahn,et al.  Peripheral Insulin Regulates a Broad Network of Gene Expression in Hypothalamus, Hippocampus, and Nucleus Accumbens , 2021, Diabetes.

[4]  J. Brewer,et al.  Intranasal Insulin Reduces White Matter Hyperintensity Progression in Association with Improvements in Cognition and CSF Biomarker Profiles in Mild Cognitive Impairment and Alzheimer’s Disease , 2021, The Journal of Prevention of Alzheimer's Disease.

[5]  J. Fadel,et al.  Intranasal insulin and orexins to treat age-related cognitive decline , 2021, Physiology & Behavior.

[6]  B. Laurent,et al.  APOE and Alzheimer’s Disease: From Lipid Transport to Physiopathology and Therapeutics , 2021, Frontiers in Neuroscience.

[7]  C. Ferrario,et al.  Insulin Bidirectionally Alters NAc Glutamatergic Transmission: Interactions between Insulin Receptor Activation, Endogenous Opioids, and Glutamate Release , 2021, The Journal of Neuroscience.

[8]  W. Banks,et al.  A historical perspective on the interactions of insulin at the blood‐brain barrier , 2021, Journal of neuroendocrinology.

[9]  J. Brewer,et al.  Safety, Efficacy, and Feasibility of Intranasal Insulin for the Treatment of Mild Cognitive Impairment and Alzheimer Disease Dementia: A Randomized Clinical Trial. , 2020, JAMA neurology.

[10]  Jamie L. Marshall,et al.  Disease-associated astrocytes in Alzheimer’s disease and aging , 2020, Nature Neuroscience.

[11]  B. Barres,et al.  Astrocytic trans-Differentiation Completes a Multicellular Paracrine Feedback Loop Required for Medulloblastoma Tumor Growth , 2020, Cell.

[12]  Qing-Rong Liu,et al.  Release of insulin produced by the choroid plexis is regulated by serotonergic signaling , 2019 .

[13]  W. Banks,et al.  Molecular Mechanisms of Intranasal Insulin in SAMP8 Mice. , 2019, Journal of Alzheimer's disease : JAD.

[14]  C. Kahn,et al.  Altered adipose tissue and adipocyte function in the pathogenesis of metabolic syndrome. , 2019, The Journal of clinical investigation.

[15]  Yi Zhang,et al.  Cell type-specific transcriptional programs in mouse prefrontal cortex during adolescence and addiction , 2019, Nature Communications.

[16]  S. Hentges,et al.  GABAergic Inputs to POMC Neurons Originating from the Dorsomedial Hypothalamus Are Regulated by Energy State , 2019, The Journal of Neuroscience.

[17]  A. Alexander,et al.  Elevated Insulin and Insulin Resistance are Associated with Altered Myelin in Cognitively Unimpaired Middle‐Aged Adults , 2019, Obesity.

[18]  B. Khakh,et al.  The Emerging Nature of Astrocyte Diversity. , 2019, Annual review of neuroscience.

[19]  E. Blalock,et al.  Long-term intranasal insulin aspart: a profile of gene expression, memory, and insulin receptors in aged F344 rats. , 2019, The journals of gerontology. Series A, Biological sciences and medical sciences.

[20]  W. Banks,et al.  Role of the Blood-Brain Barrier in Central Nervous System Insulin Resistance , 2019, Front. Neurosci..

[21]  Maria K. Lehtinen,et al.  A cellular and spatial map of the choroid plexus across brain ventricles and ages , 2019, bioRxiv.

[22]  R. Elizondo-Vega,et al.  Nutrient Sensing by Hypothalamic Tanycytes , 2019, Front. Endocrinol..

[23]  G. Baldini,et al.  The melanocortin pathway and control of appetite-progress and therapeutic implications. , 2019, The Journal of endocrinology.

[24]  Lakshmikanth L. Chikkamenahalli,et al.  Ablating astrocyte insulin receptors leads to delayed puberty and hypogonadism in mice , 2019, PLoS biology.

[25]  Linh H. Lieu,et al.  Acute effects of zinc and insulin on arcuate anorexigenic proopiomelanocortin neurons , 2019, British journal of pharmacology.

[26]  C. Kahn,et al.  Insulin signaling in the hippocampus and amygdala regulates metabolism and neurobehavior , 2019, Proceedings of the National Academy of Sciences.

[27]  Ian R. Lanza,et al.  Insulin deficiency and intranasal insulin alter brain mitochondrial function: a potential factor for dementia in diabetes , 2019, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[28]  4. Comprehensive Medical Evaluation and Assessment of Comorbidities: Standards of Medical Care in Diabetes—2019 , 2018, Diabetes Care.

[29]  W. Banks,et al.  Insulin transport across the blood–brain barrier can occur independently of the insulin receptor , 2018, The Journal of physiology.

[30]  Evangelia Karyka,et al.  Loss of IGF1R in Human Astrocytes Alters Complex I Activity and Support for Neurons , 2018, Neuroscience.

[31]  Michael E. Greenberg,et al.  Activity-Regulated Transcription: Bridging the Gap between Neural Activity and Behavior , 2018, Neuron.

[32]  T. Pedersen,et al.  The insulin receptor is expressed and functional in cultured blood-brain barrier endothelial cells but does not mediate insulin entry from blood to brain. , 2018, American journal of physiology. Endocrinology and metabolism.

[33]  T. Horvath,et al.  Insulin regulates POMC neuronal plasticity to control glucose metabolism 1 2 , 2022 .

[34]  K. Nair,et al.  Altered mitochondrial function in insulin-deficient and insulin-resistant states. , 2018, The Journal of clinical investigation.

[35]  A. Aleman,et al.  Circulating insulin-like growth factor I modulates mood and is a biomarker of vulnerability to stress: from mouse to man , 2018, Translational Psychiatry.

[36]  J. Newcomer,et al.  Metabolic Effects of Antipsychotics on Adiposity and Insulin Sensitivity in Youths: A Randomized Clinical Trial , 2018, JAMA psychiatry.

[37]  D. Wright,et al.  Deletion of the insulin receptor in sensory neurons increases pancreatic insulin levels , 2018, Experimental Neurology.

[38]  C. Kahn,et al.  Gut microbiota modulate neurobehavior through changes in brain insulin sensitivity and metabolism , 2018, Molecular Psychiatry.

[39]  Benjamin F. Grewe,et al.  Diametric neural ensemble dynamics in parkinsonian and dyskinetic states , 2018, Nature.

[40]  C. Kahn,et al.  Insulin regulates astrocyte gliotransmission and modulates behavior , 2018, The Journal of clinical investigation.

[41]  J. Shaw,et al.  IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045. , 2018, Diabetes research and clinical practice.

[42]  N. Schmitz,et al.  Investigating the longitudinal association between diabetes and anxiety: a systematic review and meta‐analysis , 2018, Diabetic medicine : a journal of the British Diabetic Association.

[43]  W. Freeman,et al.  Insulin-like growth factor receptor signaling regulates working memory, mitochondrial metabolism, and amyloid-β uptake in astrocytes , 2018, Molecular metabolism.

[44]  V. Lioutas,et al.  Intranasal insulin in Alzheimer’s dementia or mild cognitive impairment: a systematic review , 2018, Journal of Neurology.

[45]  O. Rønnekleiv,et al.  Estradiol Protects Proopiomelanocortin Neurons Against Insulin Resistance , 2018, Endocrinology.

[46]  M. Kelly,et al.  Insulin and leptin excite anorexigenic pro‐opiomelanocortin neurones via activation of TRPC5 channels , 2018, Journal of neuroendocrinology.

[47]  Steven E. Arnold,et al.  Brain insulin resistance in type 2 diabetes and Alzheimer disease: concepts and conundrums , 2018, Nature Reviews Neurology.

[48]  C. Kahn,et al.  Endothelial insulin receptors differentially control insulin signaling kinetics in peripheral tissues and brain of mice , 2017, Proceedings of the National Academy of Sciences.

[49]  E. Bézard,et al.  Insulin resistance and exendin-4 treatment for multiple system atrophy , 2017, Brain : a journal of neurology.

[50]  A. Shin,et al.  Insulin Receptor Signaling in POMC, but Not AgRP, Neurons Controls Adipose Tissue Insulin Action , 2017, Diabetes.

[51]  Bryan J. Neth,et al.  Effects of Regular and Long-Acting Insulin on Cognition and Alzheimer’s Disease Biomarkers: A Pilot Clinical Trial , 2017, Journal of Alzheimer's disease : JAD.

[52]  C. Kahn,et al.  Domain-dependent effects of insulin and IGF-1 receptors on signalling and gene expression , 2017, Nature Communications.

[53]  B. Sahakian,et al.  A randomized, double-blind, placebo-controlled, crossover trial evaluating the effect of intranasal insulin on cognition and mood in individuals with treatment-resistant major depressive disorder. , 2017, Journal of affective disorders.

[54]  Y. Xiong,et al.  An updated meta-analysis of cohort studies: Diabetes and risk of Alzheimer's disease. , 2017, Diabetes research and clinical practice.

[55]  Reiner Schulte,et al.  Heterogeneity of hypothalamic pro-opiomelanocortin-expressing neurons revealed by single-cell RNA sequencing , 2017, bioRxiv.

[56]  J. Olefsky,et al.  Inflammatory mechanisms linking obesity and metabolic disease , 2017, The Journal of clinical investigation.

[57]  D. Galimberti,et al.  Pioglitazone for the treatment of Alzheimer’s disease , 2017, Expert opinion on investigational drugs.

[58]  Peyman Golshani,et al.  New Transgenic Mouse Lines for Selectively Targeting Astrocytes and Studying Calcium Signals in Astrocyte Processes In Situ and In Vivo , 2016, Neuron.

[59]  P. Kloppenburg,et al.  Insulin-Dependent Activation of MCH Neurons Impairs Locomotor Activity and Insulin Sensitivity in Obesity. , 2016, Cell reports.

[60]  M. Sur,et al.  Jointly reduced inhibition and excitation underlies circuit-wide changes in cortical processing in Rett syndrome , 2016, Proceedings of the National Academy of Sciences.

[61]  C. Kahn,et al.  Astrocytic Insulin Signaling Couples Brain Glucose Uptake with Nutrient Availability , 2016, Cell.

[62]  S. Zaitone,et al.  Pioglitazone and exenatide enhance cognition and downregulate hippocampal beta amyloid oligomer and microglia expression in insulin-resistant rats. , 2016, Canadian journal of physiology and pharmacology.

[63]  A. Gjedde,et al.  In Alzheimer’s Disease, 6-Month Treatment with GLP-1 Analog Prevents Decline of Brain Glucose Metabolism: Randomized, Placebo-Controlled, Double-Blind Clinical Trial , 2016, Front. Aging Neurosci..

[64]  Shuai Liu,et al.  Consumption of palatable food primes food approach behavior by rapidly increasing synaptic density in the VTA , 2016, Proceedings of the National Academy of Sciences.

[65]  P. Lustman,et al.  Antidepressant medication use and glycaemic control in co-morbid type 2 diabetes and depression. , 2016, Family practice.

[66]  Paul Witkovsky,et al.  Insulin enhances striatal dopamine release by activating cholinergic interneurons and thereby signals reward , 2015, Nature Communications.

[67]  D. Mott,et al.  Hippocampal Insulin Resistance Impairs Spatial Learning and Synaptic Plasticity , 2015, Diabetes.

[68]  D. Butterfield,et al.  Alteration of mTOR signaling occurs early in the progression of Alzheimer disease (AD): analysis of brain from subjects with pre‐clinical AD, amnestic mild cognitive impairment and late‐stage AD , 2015, Journal of neurochemistry.

[69]  D. Song,et al.  Orexin A regulates plasma insulin and leptin levels in a time-dependent manner following a glucose load in mice , 2015, Diabetologia.

[70]  C. Kahn,et al.  Insulin resistance in brain alters dopamine turnover and causes behavioral disorders , 2015, Proceedings of the National Academy of Sciences.

[71]  Yen-Chu Lin,et al.  Sensory Detection of Food Rapidly Modulates Arcuate Feeding Circuits , 2015, Cell.

[72]  C. Lyketsos,et al.  Modifiable predictors of dementia in mild cognitive impairment: a systematic review and meta-analysis. , 2015, The American journal of psychiatry.

[73]  J. Brüning,et al.  Central insulin signaling modulates hypothalamus–pituitary–adrenal axis responsiveness , 2014, Molecular metabolism.

[74]  Chun-ling Dai,et al.  Intranasal insulin restores insulin signaling, increases synaptic proteins, and reduces Aβ level and microglia activation in the brains of 3xTg-AD mice , 2014, Experimental Neurology.

[75]  Akihiro Yamanaka,et al.  Concurrent and robust regulation of feeding behaviors and metabolism by orexin neurons , 2014, Neuropharmacology.

[76]  W. Hwu,et al.  Systemic administration of a recombinant AAV1 vector encoding IGF-1 improves disease manifestations in SMA mice. , 2014, Molecular therapy : the journal of the American Society of Gene Therapy.

[77]  C. Kahn,et al.  Insulin Action in Brain Regulates Systemic Metabolism and Brain Function , 2014, Diabetes.

[78]  O. Rønnekleiv,et al.  Insulin excites anorexigenic proopiomelanocortin neurons via activation of canonical transient receptor potential channels. , 2014, Cell metabolism.

[79]  P. Gluckman,et al.  Cyclic glycine-proline regulates IGF-1 homeostasis by altering the binding of IGFBP-3 to IGF-1 , 2014, Scientific Reports.

[80]  I. Torres-Aleman,et al.  Astrocytes require insulin-like growth factor I to protect neurons against oxidative injury , 2014, F1000Research.

[81]  M. Roe,et al.  Characterization of mice expressing Ins1 gene promoter driven CreERT recombinase for conditional gene deletion in pancreatic β-cells , 2014, Islets.

[82]  R. Dolmetsch,et al.  SHANK3 and IGF1 restore synaptic deficits in neurons from 22q13 deletion syndrome patients , 2013, Nature.

[83]  T. Sasaoka,et al.  Hypothalamic orexin prevents hepatic insulin resistance induced by social defeat stress in mice , 2013, Neuropeptides.

[84]  A. Bhansali,et al.  Diabetes mellitus and risk of dementia: A meta‐analysis of prospective observational studies , 2013, Journal of diabetes investigation.

[85]  C. Kahn,et al.  Reduction of the Cholesterol Sensor SCAP in the Brains of Mice Causes Impaired Synaptic Transmission and Altered Cognitive Function , 2013, PLoS biology.

[86]  D. Vancampfort,et al.  Prevalence of metabolic syndrome and metabolic abnormalities in schizophrenia and related disorders--a systematic review and meta-analysis. , 2013, Schizophrenia bulletin.

[87]  N. Schmitz,et al.  Association of diabetes with anxiety: a systematic review and meta-analysis. , 2013, Journal of psychosomatic research.

[88]  S. Heller,et al.  Prevalence of depression among young people with Type 1 diabetes: a systematic review , 2013, Diabetic medicine : a journal of the British Diabetic Association.

[89]  Shuai Liu,et al.  Insulin induces long-term depression of VTA dopamine neurons via an endocannabinoid-mediated mechanism , 2013, Nature Neuroscience.

[90]  D. Ståhl,et al.  A Systematic Review and Meta-analysis of the Association Between Depression and Insulin Resistance , 2013, Diabetes Care.

[91]  S. Kennedy,et al.  A randomized, double‐blind, controlled trial evaluating the effect of intranasal insulin on neurocognitive function in euthymic patients with bipolar disorder , 2012, Bipolar disorders.

[92]  C. Kahn,et al.  Tissue–Specific Insulin Signaling, Metabolic Syndrome, and Cardiovascular Disease , 2012, Arteriosclerosis, thrombosis, and vascular biology.

[93]  K. Rascati,et al.  Use of antidepressant agents and the risk of type 2 diabetes , 2012, European Journal of Clinical Pharmacology.

[94]  An Pan,et al.  Bidirectional Association Between Depression and Metabolic Syndrome , 2012, Diabetes Care.

[95]  J. Schneider,et al.  Demonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline. , 2012, The Journal of clinical investigation.

[96]  I. Torres-Aleman,et al.  The many faces of insulin-like peptide signalling in the brain , 2012, Nature Reviews Neuroscience.

[97]  T. Montine,et al.  Intranasal Insulin Therapy for Alzheimer Disease and Amnestic Mild Cognitive Impairment A Pilot Clinical Trial , 2011 .

[98]  Simon Hess,et al.  Role for insulin signaling in catecholaminergic neurons in control of energy homeostasis. , 2011, Cell metabolism.

[99]  T. Montine,et al.  Diabetes and insulin in regulation of brain cholesterol metabolism. , 2010, Cell metabolism.

[100]  Xiaoxiao Hu,et al.  Brain expression of Cre recombinase driven by pancreas‐specific promoters , 2010, Genesis.

[101]  A. F. Thomsen,et al.  Treatment with antipsychotics and the risk of diabetes in clinical practice , 2010, British Journal of Psychiatry.

[102]  Y. Le,et al.  Norepinephrine Promotes Microglia to Uptake and Degrade Amyloid β Peptide through Upregulation of Mouse Formyl Peptide Receptor 2 and Induction of Insulin-Degrading Enzyme , 2010, The Journal of Neuroscience.

[103]  B. Wicksteed,et al.  Conditional Gene Targeting in Mouse Pancreatic β-Cells , 2010, Diabetes.

[104]  Michael Gold,et al.  Rosiglitazone Monotherapy in Mild-to-Moderate Alzheimer’s Disease: Results from a Randomized, Double-Blind, Placebo-Controlled Phase III Study , 2010, Dementia and Geriatric Cognitive Disorders.

[105]  F. Pouwer,et al.  Type 2 diabetes mellitus as a risk factor for the onset of depression: a systematic review and meta-analysis , 2010, Diabetologia.

[106]  V. Routh,et al.  Brain Insulin Action Regulates Hypothalamic Glucose Sensing and the Counterregulatory Response to Hypoglycemia , 2010, Diabetes.

[107]  B. Lowell,et al.  Direct insulin and leptin action on pro-opiomelanocortin neurons is required for normal glucose homeostasis and fertility. , 2010, Cell metabolism.

[108]  Kevin W. Williams,et al.  Segregation of Acute Leptin and Insulin Effects in Distinct Populations of Arcuate Proopiomelanocortin Neurons , 2010, The Journal of Neuroscience.

[109]  Rosemary O’Connor,et al.  Defects in IGF-1 receptor, insulin receptor and IRS-1/2 in Alzheimer's disease indicate possible resistance to IGF-1 and insulin signalling , 2010, Neurobiology of Aging.

[110]  S. Sternson,et al.  AGRP neurons are sufficient to orchestrate feeding behavior rapidly and without training , 2010, Nature Neuroscience.

[111]  T. Horvath,et al.  Divergent Regulation of Energy Expenditure and Hepatic Glucose Production by Insulin Receptor in Agouti-Related Protein and POMC Neurons , 2009, Diabetes.

[112]  J. Brüning,et al.  Hormone and glucose signalling in POMC and AgRP neurons , 2009, The Journal of physiology.

[113]  Sherita Hill Golden,et al.  Depression and Type 2 Diabetes Over the Lifespan , 2008, Diabetes Care.

[114]  J. Lieberman,et al.  Antipsychotic drug mechanisms: links between therapeutic effects, metabolic side effects and the insulin signaling pathway , 2008, Molecular Psychiatry.

[115]  T. van Amelsvoort,et al.  Hepatic insulin resistance in antipsychotic naive schizophrenic patients: stable isotope studies of glucose metabolism. , 2008, The Journal of clinical endocrinology and metabolism.

[116]  F. Cavagnini,et al.  Neuroendocrine control of food intake. , 2008, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[117]  K. Briski,et al.  Type II glucocorticoid receptor involvement in habituated activation of lateral hypothalamic area orexin-A-immunopositive neurons during recurring insulin-induced hypoglycemia , 2006, Neuroscience Research.

[118]  S. Akira,et al.  Role of hepatic STAT3 in brain-insulin action on hepatic glucose production. , 2006, Cell metabolism.

[119]  J. Jeon,et al.  MCH-/- mice are resistant to aging-associated increases in body weight and insulin resistance. , 2006, Diabetes.

[120]  S. Kennedy,et al.  The effect of antidepressants on glucose homeostasis and insulin sensitivity: synthesis and mechanisms , 2006, Expert opinion on drug safety.

[121]  C. Kahn,et al.  Insulin signaling in the central nervous system is critical for the normal sympathoadrenal response to hypoglycemia. , 2005, Diabetes.

[122]  E. Hafen,et al.  Longer lifespan, altered metabolism, and stress resistance in Drosophila from ablation of cells making insulin-like ligands. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[123]  C. Kahn,et al.  Role for neuronal insulin resistance in neurodegenerative diseases , 2004 .

[124]  R. Dempsey,et al.  Stroke‐induced progenitor cell proliferation in adult spontaneously hypertensive rat brain: effect of exogenous IGF‐1 and GDNF , 2003, Journal of neurochemistry.

[125]  T. Laessig,et al.  Insulin-Like Growth Factor-I Blocks Bcl-2 Interacting Mediator of Cell Death (Bim) Induction and Intrinsic Death Signaling in Cerebellar Granule Neurons , 2002, The Journal of Neuroscience.

[126]  J. Javitch,et al.  PI 3‐kinase regulation of dopamine uptake , 2002, Journal of neurochemistry.

[127]  V. Piëch,et al.  Subunit-specific temporal and spatial patterns of AMPA receptor exocytosis in hippocampal neurons , 2001, Nature Neuroscience.

[128]  K. Freedland,et al.  Association of Depression and Diabetes Complications: A Meta-Analysis , 2001, Psychosomatic medicine.

[129]  K. Freedland,et al.  The prevalence of comorbid depression in adults with diabetes: a meta-analysis. , 2001, Diabetes care.

[130]  M. Bennett,et al.  Insulin promotes rapid delivery of N-methyl-d- aspartate receptors to the cell surface by exocytosis , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[131]  Mark von Zastrow,et al.  Regulation of AMPA receptor endocytosis by a signaling mechanism shared with LTD , 2000, Nature Neuroscience.

[132]  Rüdiger Klein,et al.  Role of Brain Insulin Receptor in Control of Body Weight and Reproduction , 2000 .

[133]  Yu Tian Wang,et al.  Regulation of AMPA Receptor–Mediated Synaptic Transmission by Clathrin-Dependent Receptor Internalization , 2000, Neuron.

[134]  T. Sakurai,et al.  Neurons containing orexin in the lateral hypothalamic area of the adult rat brain are activated by insulin-induced acute hypoglycemia , 1999, Neuroscience Letters.

[135]  D. Monaghan,et al.  Insulin Causes a Transient Tyrosine Phosphorylation of NR2A and NR2B NMDA Receptor Subunits in Rat Hippocampus , 1999, Journal of neurochemistry.

[136]  R. Rubin,et al.  Persistence of depressive symptoms in diabetic adults. , 1999, Diabetes care.

[137]  B. Lowell,et al.  Mice lacking melanin-concentrating hormone are hypophagic and lean , 1998, Nature.

[138]  P. Gluckman,et al.  Co-ordinated and cellular specific induction of the components of the IGF/IGFBP axis in the rat brain following hypoxic-ischemic injury. , 1998, Brain research. Molecular brain research.

[139]  S. Carr,et al.  Orexins and Orexin Receptors: A Family of Hypothalamic Neuropeptides and G Protein-Coupled Receptors that Regulate Feeding Behavior , 1998, Cell.

[140]  G. Schellenberg,et al.  Cerebrospinal fluid and plasma insulin levels in Alzheimer's disease , 1998, Neurology.

[141]  R. Carney,et al.  Effects of Alprazolam on Glucose Regulation in Diabetes: Results of double-blind, placebo-controlled trial , 1995, Diabetes Care.

[142]  C. Kahn,et al.  Variation in insulin receptor messenger ribonucleic acid expression in human and rodent tissues. , 1987, Molecular endocrinology.

[143]  G. King,et al.  Receptor-mediated transport of insulin across endothelial cells. , 1985, Science.

[144]  R. G. Hoskins,et al.  RESULTS OF INSULIN AND EPINEPHRINE TOLERANCE TESTS IN SCHIZOPHRENIC PATIENTS AND IN NORMAL SUBJECTS , 1943 .

[145]  J. Kasanin.  THE BLOOD SUGAR CURVE IN MENTAL DISEASE: II. THE SCHIZOPHRENIC (DEMENTIA PRAECOX) GROUPS , 1926 .

[146]  C. Kahn,et al.  Insulin receptor signaling in normal and insulin-resistant states. , 2014, Cold Spring Harbor perspectives in biology.

[147]  N. Chattipakorn,et al.  PPARγ agonist improves neuronal insulin receptor function in hippocampus and brain mitochondria function in rats with insulin resistance induced by long term high-fat diets. , 2012, Endocrinology.

[148]  M. Stein,et al.  A randomized controlled trial of high-dose vitamin D2 followed by intranasal insulin in Alzheimer's disease. , 2011, Journal of Alzheimer's disease : JAD.

[149]  David R. Williams,et al.  Mental disorders among persons with diabetes--results from the World Mental Health Surveys. , 2008, Journal of psychosomatic research.

[150]  G. Schellenberg,et al.  Intranasal insulin administration dose-dependently modulates verbal memory and plasma amyloid-beta in memory-impaired older adults. , 2008, Journal of Alzheimer's disease : JAD.

[151]  J. Wands,et al.  Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease--is this type 3 diabetes? , 2005, Journal of Alzheimer's disease : JAD.

[152]  K. Jellinger,et al.  Brain insulin and insulin receptors in aging and sporadic Alzheimer's disease , 1998, Journal of Neural Transmission.